Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Systemic scleroderma
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Pathophysiology== Overproduction of collagen is thought to result from an autoimmune dysfunction, in which the immune system starts to attack the [[kinetochore]] of the chromosomes. This would lead to genetic malfunction of nearby genes. [[T cell]]s accumulate in the skin; these are thought to secrete [[cytokine]]s and other proteins that stimulate collagen deposition. Stimulation of the [[fibroblast]], in particular, seems to be crucial to the disease process, and studies have converged on the potential factors that produce this effect.<ref name=JimenezDerk/> [[File:NIH 3T3.jpg|thumb|Fibroblasts]] A significant player in the process is [[transforming growth factor]] (TGFβ). This protein appears to be overproduced, and the fibroblast (possibly in response to other stimuli) also overexpresses the receptor for this mediator. An intracellular pathway (consisting of ''[[SMAD2]]''/''[[SMAD3]]'', ''[[SMAD4]]'', and the inhibitor ''[[SMAD7]]'') is responsible for the secondary messenger system that induces [[transcription (genetics)|transcription]] of the proteins and enzymes responsible for collagen deposition. ''Sp1'' is a [[transcription factor]] most closely studied in this context. Apart from TGFβ, [[connective tissue growth factor]] (CTGF) has a possible role.<ref name=JimenezDerk/> Indeed, a common ''CTGF'' gene polymorphism is present at an increased level in systemic sclerosis.<ref>{{cite journal |vauthors=Fonseca C, Lindahl GE, Ponticos M, etal |title=A polymorphism in the CTGF promoter region associated with systemic sclerosis |journal=N. Engl. J. Med. |volume=357 |issue=12 |pages=1210–20 |date=September 2007 |pmid=17881752 |doi=10.1056/NEJMoa067655 |s2cid=7042371 |doi-access=free }}</ref> Damage to [[endothelium]] is an early abnormality in the development of scleroderma, and this, too, seems to be due to collagen accumulation by fibroblasts, although direct alterations by cytokines, [[platelet]] adhesion, and a type II hypersensitivity reaction similarly have been implicated. Increased [[endothelin]] and decreased [[vasodilation]] have been documented.<ref name=JimenezDerk/> Jimenez and Derk<ref name=JimenezDerk/> describe three theories about the development of scleroderma: * The abnormalities are primarily due to a physical agent, and all other changes are secondary or reactive to this direct insult. * The initial event is fetomaternal cell transfer causing microchimerism, with a second summative cause (e.g. environmental) leading to the actual development of the disease. * Physical causes lead to phenotypic alterations in susceptible cells (e.g. due to genetic makeup), which then effectuate DNA changes that alter the cells' behavior.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)